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Abstract
Background: The use of tocolytic hospitalization in antenatal care is controversial and worthy of
more research. We investigated individual, institutional, and area factors that affect the use of
tocolytic hospitalizations in Taiwan where fertility has rapidly declined.
Methods: Longitudinal data from the 1996 to 2004 National Health Insurance Research Database
in Taiwan were used to identify tocolytic hospitalizations. The probit model was used to estimate
factors associated with tocolytic hospitalizations.
Results:  The decline in fertility was significantly associated with the probability of tocolytic
hospitalizations. Several physician and institutional factors-including physician's age, hospital
ownership, accreditation status, bed size, and teaching status-were also significantly correlated to
the dependent variables.
Conclusions: The provision of inpatient tocolysis is influenced not only by clinical considerations
but also by physician, institutional, and area factors unrelated to clinical need. Fertility declines in
Taiwan may have led obstetricians/gynecologists to provide more tocolysis to make up for their
lost income. If the explanation is further validated, reimbursement policies may need to be
reviewed to correct for overuse of inpatient tocolysis. The correlation could also be explained by
the increasing use of artificial reproductive technologies and higher social value of newborns. In
addition, the physician and institutional variations observed in the study indicate potential misuse
of inpatient tocolysis that warrant further investigation.
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Background
Antenatal care generally improves maternal and infant
health [1]. The most commonly stated reason for antena-
tal hospitalizations is having symptoms of threatened pre-
term labor [2-8]. Tocolytic treatment, which uses
pharmacologic agents to inhibit uterine contractions and
to prevent delivery before the completion of 37 weeks of
gestation, is touted to reduce perinatal morbidity and
mortality associated with threatened preterm labor [9,10].
However, the use of tocolytic hospitalization in antenatal
care is controversial due to the potential adverse health
effects and conflicting evidence of effectiveness [8,11-15].
Research indicated that antenatal hospitalizations with a
pregnancy-related diagnosis may impose significant eco-
nomic and psychosocial burdens on pregnant women and
their family and may increase costs for the health care sys-
tem [3,13,16]. Several U.S. studies showed that tocolytic
treatment accounts for one-quarter to nearly one-half of
all antenatal hospitalizations [3,5-7,17]. Examining the
conditions under which women receive tocolytic treat-
ment, including factors unrelated to the woman's clinical
need, is necessary to understand whether the treatment
are always justified.
Several studies have attempted to identify factors that lead
to tocolytic hospitalizations. Most of these studies have
focused on individual factors, such as pregnancy compli-
cations [3], adverse reproductive health history [5,14,18],
severe life events [18], age [3-7], race [3,4,18], and insur-
ance status [3,4,18]. By focusing on these individual vari-
ables, existing studies assume that the decision to provide
antenatal and tocolytic treatments is predominantly a
clinical consideration, unrelated to organizational and
health care market conditions that have been found in
numerous studies to affect medical service use [19-21].
Moreover, the majority of existing research uses either a
cross-sectional study design or data from a selected
patient subpopulation. It can be argued that a change in
market conditions may encourage obstetricians and gyne-
cologists to admit more women for tocolytic treatments
for reasons unrelated to clinical need. This argument is
testable when there is sufficient temporal variation in
market conditions.
The purpose of this study is to conduct a longitudinal and
population-based analysis of individual, organizational,
and market factors that influence tocolytic hospitaliza-
tions. Data for this study were collected in Taiwan
between 1996 and 2004. Two recent developments in Tai-
wan make the study particularly interesting. First, Taiwan
has experienced a fertility decline since 1984 and the
decline has been more dramatic in the last ten years. The
number of live births in Taiwan was 325,545 in 1996, and
it decreased to 204,414 in 2007 [22], giving Taiwan one
of the lowest fertility rates among developed countries
[23]. The fertility decline may have created an incentive
for obstetricians and gynecologists to provide more toco-
lytic treatments to make up for lost revenue due to fewer
births. The rapid fertility decline and its potential impact
on tocolytic hospitalizations should be considered in
empirical specifications.
Second, in March 1995, Taiwan implemented a new
National Health Insurance program that provides health
insurance coverage to the entire population. Currently,
more than 95 percent of hospitals and clinics are con-
tracted to provide health care services in the NHI program
[24]. Physicians participating in the National Health
Insurance program are paid according to fixed rates set by
the Bureau of National Health Insurance, and the con-
tracted medical institutions are paid mainly on a fee-for-
service basis. Universal health insurance in Taiwan and
the single-payer design offer a favorable research setting
that prevents the use of cumbersome methods to control
for variation and change in health insurance coverage
often seen in countries, such as the U.S., that have frag-
mented health care systems.
Methods
We employed a longitudinal design and used data from
the National Health Insurance Research Database, which
is maintained by the National Health Research Institute.
Specifically, information from the National Health Insur-
ance Research Database from 1996 to 2004 was combined
into a single file that contained discharge records of
National Health Insurance enrollees: registry for con-
tracted medical facilities, registry for medical personnel,
registry for contracted beds, registry for beneficiaries, reg-
istry for board-certified specialists, hospital discharge file,
and registry for catastrophic illness patients. We were able
to link discharge data with hospital and provider informa-
tion because each discharge record contained patient, hos-
pital and provider IDs. Further, we obtained data on the
general fertility rate and population size from the Taiwan-
Fuchien Demographic Fact Book, 1997-2004, and merged
them with the National Health Insurance Research Data-
base by hospitals' area codes.
To ensure confidentiality, all IDs were scrambled. Any
information that could be used to identify individual
enrollees was also deleted before the data were released to
the researchers. Because the risk of identifying individuals
from the released data is minimal, the National Health
Research Institute approved our use of the National
Health Insurance Research Database and the institutional
review boards at the University of North Carolina at
Chapel Hill and the Kaohsiung Medical University deter-
mined that the study did not constitute human subjects
research and granted a waiver.BMC Pregnancy and Childbirth 2009, 9:59 http://www.biomedcentral.com/1471-2393/9/59
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The study population included women who gave birth
between January 1, 1997 and December 31, 2004. To be
consistent with previous research, the following exclusion
criteria were applied: (1) women hospitalized for early
pregnancy loss (ICD-9-CM 630-634 and 637-639) or elec-
tive termination (ICD-9-CM 635 and 636); (2) women
aged above 50 or below 15; (3) women whose attending
obstetrician/gynecologist's age was below 25 or above 75;
and (4) women with multiple deliveries. Pregnancies in
women under 15 or over 50 years old are atypical. Clini-
cians in Taiwan, as elsewhere, are rarely qualified as obste-
tricians/gynecologists before the age of twenty-five or after
seventy-five. Women with multiple pregnancies may be
particularly prone to antenatal hospitalizations [25].
Because our focus was on tocolytic hospitalizations,
defined as ICD-9-CM codes 644.0 to 644.4 listed in the
diagnosis field, women contraindicated for tocolysis
according to the current standard of care and women
noted to have additional medical conditions that could
have been treated with medications misclassified with toc-
olysis were also excluded [26]. Those exclusion conditions
included hypertension/eclampsia/pre-eclampsia (ICD-9-
CM 642), excessive maternal bleeding/abrupted placenta/
placenta previa (ICD-9-CM 762.0, 762.1, 762.2), prema-
ture rupture of membrances/incompetent cervix (ICD-9-
CM 761), fetal distress (ICD-9-CM 656.3, 663.0, 768.3
and 768.4), maternal infection/chorioamnionitis (ICD-9-
CM 762.7), and congenital abnormalities (ICD-9-CM
740-759). Based on the above inclusion and exclusion cri-
teria, the final sample of our study contained 83,619
observations of tocolytic hospitalization. Totally, 64,098
cases were excluded in our study.
The unit of analysis was a pregnancy, and the dependent
variable was whether a tocolytic hospitalization occurred.
The independent variables fell into four categories: indi-
vidual, physician, institutional, and area factors. Individ-
ual factors included the woman's age, wage, having prior
pregnancy-associated hospitalizations (ICD-9-CM codes
from 640 to 676 with a fifth digit of "0" or "3", or any
diagnosis in combination with a code V22 [normal preg-
nancy] or V23 [high-risk pregnancy]), having a major dis-
ease card (an indicator of having a severe health problem
such as malignant neoplasm, end-stage renal disease,
chronic psychotic disorder, cirrhosis of the liver, acquired
immunodeficiency syndrome, and schizophrenia), and
previous year's inpatient expenses. Age, having a major
disease card, having prior pregnancy-associated hospitali-
zations, and previous year's inpatient expenses captured
the health conditions of pregnant women that increased
the likelihood of tocolytic hospitalization. Our analysis
was focused on the use of tocolytic hospitalizations (ICD-
9-CM codes from 644.0 to 644.4), which are a subset of
antenatal hospitalizations (ICD-9-CM codes from 640 to
676 with a fifth digit of "0" or "3", or any diagnosis in
combination with a code V22 [normal pregnancy] or V23
[high-risk pregnancy]).
Physician characteristics included attending obstetrician/
gynecologist's age and gender. The attending obstetrician/
gynecologist's years in the specialty was not included
because it was highly correlated with age [27,28]. Institu-
tional factors included hospital ownership (public, pri-
vate non-profit, or proprietary), teaching status (teaching
versus non-teaching institution), accreditation status
(medical center, regional hospital, district hospital, or
obstetric/gynecological clinic), and number of beds. In
Taiwan, obstetric/gynecological clinics are allowed to
have up to nine beds for inpatient services and can pro-
vide inpatient tocolytic treatment. An area factor, the
annual general fertility rate in the region, was included.
The general fertility rate was age-adjusted. Geographic
areas in Taiwan are delineated based upon the health care
service regions reported by the Department of Health in
Taiwan. There are twenty-one regions. Finally, we
included a full set of regional and time dummies to con-
trol for the regional and time fixed effects.
Because the dependent variable (having a tocolytic hospi-
talization) was binary, we estimated a probit model for
this outcome. The probit model is a popular specification
for a binary-response model that emerges from the nor-
mal cumulative distribution function (CDF). The probit
model on the full sample was to predict the probability of
a tocolytic hospitalization. In this model the probability
will lie between 0 and 1 and vary nonlinearly with the
explanatory variables. These properties are in contrast
with the linear probability model where the probability
increases linearly with the explanatory variables and may
lie outside the 0-1 range.
The probit model can be written as:
where Y is a dichotomous variable indicating whether a
mother had a tocolyic hospitalization (0 if no, 1 if yes), Φ
is the standard normal cumulative distribution, i indexes
individual patient, g  indexes the obstetrician/gynecolo-
gist, h indexes the hospital, r indexes the region, t indexes
time, the vector W represents all exogenous explanatory
variables, γ is a vector of coefficients on W, and ν is the
random error assumed to be independent of all other
error terms.
Specifically,  W  = (X,  Z,  H,  ln(Fertilityrt),  δr,  ςt), where,
ln(Fertilityrt) is the natural logarithm of regional age-
adjusted fertility rate in year t, δr is a set of dummies rep-
resenting regions, ςt is a full set of year dummies, X is a
Pr( | ) [ , ] YW W V ighrt >= 0 Φ γBMC Pregnancy and Childbirth 2009, 9:59 http://www.biomedcentral.com/1471-2393/9/59
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vector of observable patient characteristics, Z is a vector of
observable physician characteristic, and H is a vector of
observable hospital characteristics. The regional fixed
effects (δr) would capture unobserved regional prefer-
ences for care or hospital selection.
The estimated parameters in probit model are not are not
directly interpretable, but they can be translated into mar-
ginal effects. The magnitude of the marginal effect repre-
sents a percentage point change in the probability as a
function of a change in a certain explanatory variable
while keeping all the other covariates constant. Empiri-
cally, we use the "average of the probabilities" method to
calculate the marginal effects of each covariate.
Results
Table 1 contains summary statistics of the number of sin-
gleton deliveries, antenatal hospitalizations, and tocolytic
hospitalizations from 1997 to 2004. Among the
1,979,311 women who gave birth during the study
period, 83,619 experienced tocolytic hospitalizations.
Notably, the use of tocolytic hospitalizations was not par-
allel to the decreasing number of newborns in recent years
in Taiwan. The rates of inpatient antenatal hospitaliza-
tions, and tocolytic hospitalizations were 5.24% and
4.22%, lower than those reported in the literature, despite
the use of similar inclusion and exclusion criteria in our
sample selection [3,4,7,8]. It is possible that the coverage
of ten prenatal outpatient visits in Taiwan's Nation Health
Insurance may allow early detections of pregnancy-related
problems and reduce the need for tocolytic hospitaliza-
tions.
The descriptive statistics in Table 2 indicate that women
experiencing tocolytic hospitalizations were generally
older (29.1 vs. 28.2 years old), had poorer health status in
terms of having a major disease card (2.1% vs. 1.3%), had
prior pregnancy-associated hospitalizations (38.2% vs.
3.6%), and had higher inpatient expenses in the previous
year (NT$3,968.9 vs. NT$3,637.2), compared to all
women who gave birth. Women experiencing tocolytic
hospitalizations also had higher wages (NT$18,393.5 vs.
NT$17,202.9). The last column of Table 2 showed the
descriptive statistics about the excluded population, and
they were also older and unhealthier compared to the gen-
eral population.
Results on the use of tocolytic hospitalizations are
reported in Table 3. All estimates are reported with robust
standard errors to fix the heteroskedasticity problem in
probit model. According to the probit model, several
explanatory variables such as women's age, wage, having
prior pregnancy-associated hospitalizations, previous
year's inpatient expenses, hospital bed size, public hospi-
tal ownership, hospital accreditation status (non-clinic),
teaching hospital, attending obstetrician/gynecologist's
age displayed a positive and statistically significant associ-
ation with the probability of having a tocolytic hospitali-
zation. Private non-profit hospital ownership was
negatively correlated with the propensity of having a toc-
olytic hospitalization. Interestingly, regional fertility rate
was negatively associated with tocolytic hospitalization,
indicating that a decrease in the regional fertility rate was
significantly correlated with an increase in the propensity
of tocolytic hospitalization. In terms of marginal effects, a
one percent decrease in the regional fertility rate was asso-
ciated with a 0.221 percentage points increase on average
in the probability of having a tocolytic hospitalization.
The interpretations of marginal effects of other explana-
tory variables are similar, e.g., teaching hospitals are asso-
Table 1: Summary statistics of singleton deliveries and antenatal hospitalizations, 1997-2004
Year Number of Singleton 
deliveries
Total number of antenatal 
hospitalizations
Total number of tocolytic 
hospitalizations
Number of excluded cases
1997 302,049 13,341 9,145 8,814
1998 246,244 12,236 9,816 8,262
1999 257,326 12,441 10,217 9,025
2000 276,786 13,311 11,567 8,890
2001 239,626 13,205 10,682 7,644
2002 232,192 13,149 10,862 7,495
2003 216,390 13,310 10,732 6,609
2004 208,698 12,318 10,598 7,359
Total 1,979,311 103,811 83,619 64,098
The exclusion population include: (1) women hospitalized for early pregnancy loss (ICD-9-CM 630-634 and 637-639) or elective termination (ICD-
9-CM 635 and 636); (2) women aged above 50 or below 15; (3) women whose attending obstetrician/gynecologist's age was below 25 or above 75; 
(4) women with multiple deliveries (ICD-9-CM 651-652); (5) hypertension/eclampsia/pre-eclampsia (ICD-9-CM 642); (6) excessive maternal 
bleeding/abrupted placenta/placenta previa (ICD-9-CM 762.0, 762.1, 762.2); (7) premature rupture of membrances/incompetent cervix (ICD-9-CM 
761); (8) fetal distress (ICD-9-CM 656.3, 663.0, 768.3 and 768.4) (9) maternal infection/chorioamnionitis (ICD-9-CM 762.7); and (10) congenital 
abnormalities (ICD-9-CM 740-759).BMC Pregnancy and Childbirth 2009, 9:59 http://www.biomedcentral.com/1471-2393/9/59
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Table 2: Summary statistics of the study population
Variables Women who gave birth Women who gave birth and had a 
tocolytic hospitalization
Excluded population
Individual factors
Age (S.D.) 28.22 (4.9) 29.12 (5.3) 29.27 (5.9)
Wage (S.D.) 17,202.93
(16,325.7)
18,393.48
(17,256.6)
18,215.43
(16,957.2)
Having a major disease card (%) 25,719 (1.3%) 1,733 (2.1%) 2,006 (1.9%)
Having hospitalizations for preterm 
labor before (%)
71,876 (3.6%) 31,935 (38.2%) 18,897 (18.2%)
Previous year's inpatient expenses 
(S.D.)
3,637.16
(14198.1)
3,968.92
(14444.2)
3,789.52 (14264.86)
Observations 1,979,311 83,619 64,098
Table 3: Probit model for the use of tocolytic hospitalizations
Variables Probit model Marginal effect
Constant term -3.028 (0.423)** -2.326 (0.074)**
Individual factors
Age 0.026 (0.001)** -0.010 (0.0002)**
Wage 0.004 (0.0001)** 0.001 (0.0001)**
Having a major disease card 0.015 (0.018) 0.061 (0.065)
Having pregnancy-associated hospitalizations before 0.428 (0.006)** 0.665 (0.018)**
Previous year's inpatient expenses 0.001 (0.0002)** 0.027 (0.001)**
Institutional factors
Bed size 0.004 (0.001)** 0.007 (0.001)**
Ownership
Public 0.059 (0.010)** -0.020 (0.004)**
Private non-profit -0.102 (0.010)** -0.042 (0.004)**
Proprietary (Reference)
Accreditation status
Medical center 0.392 (0.021)** 0.013 (0.007)**
Regional hospital 0.102 (0.017)** 0.021 (0.006)**
District hospital 0.113 (0.013)** 0.015 (0.005)**
Clinic (Reference)
Teaching status
Teaching 0.128 (0.011)** 0.050 (0.004)**
Non-teaching (Reference)
Physician factors
Male gender -0.012 (0.010) -0.004 (0.002)
Age 0.003 (0.0005)** 0.019 (0.001)**
Area factor
Logged regional fertility rate -0.539 (0.112)** -0.221 (0.042)**
Observations 1,979,311 1,979,311
Log-likelihood -148,762.7
Robust standard errors are in parentheses. The three models also include a full set of time and regional dummies. *Statistically significant at the 10% 
level. **Statistically significant at the 5% level.BMC Pregnancy and Childbirth 2009, 9:59 http://www.biomedcentral.com/1471-2393/9/59
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ciated with a 0.05 percentage points increase on average in
the probability of having a tocolytic hospitalization than
non-teaching hospitals.
Discussion
Our study provides a comprehensive analysis of tocolytic
hospitalizations in Taiwan. The validity of our study may
be affected by the inherent limitations of the administra-
tive data (e.g., limited diagnostic and clinical information,
reporting errors) and the lack of detailed patient-level data
such as gestational age [29], parity, pre-pregnancy body
mass index, gestational weight gain [30,31], neonatal out-
comes (e.g., prematurity and extreme prematurity), toco-
lytic agents (e.g., ritodrine and nifedipine), and antenatal
steroids (e.g., glucocorticoids). Our findings may have
limited generality because the data were somewhat dated
and because of the particular medical practice and health
insurance situations in Taiwan. Despite these caveats, sev-
eral of our findings are noteworthy and may have impli-
cations for countries that experience a similar decline in
fertility.
An important finding is that declining fertility was associ-
ated with increased use of tocolytic hospitalizations.
There are several explanations for this finding. The first is
the financial incentive. In Taiwan, obstetricians/gynecolo-
gists either are employed by hospitals (on hospital pay-
roll) or operate their own clinics. The salary of those
employed by hospitals usually constitutes two compo-
nents: the contracted annual salary and a bonus based on
the volume and level of services they provide. The income
of self-employed obstetricians/gynecologists is affected by
the volume of services they provide. As fertility decline
reduces the number of deliveries-an important revenue
source-obstetricians/gynecologists as well as hospitals
may have an incentive under the current fee-for-service
payment structure to provide more inpatient tocolysis
services in order to maintain, or increase, their revenue.
Patients are unlikely to object, because they bear no finan-
cial risk under the National Health Insurance regime and
because they lack the knowledge to assess the medical risk
of tocolysis. To the extent this explanation is valid, our
study offers a precautionary note to countries that have
experienced a fertility decline and where the health care
payment system similarly presents a financial incentive
for obstetricians/gynecologists and hospitals to offer
unwarranted services.
Second, tocolytic treatments may be related to the condi-
tions accompanying the declining fertility rate in Taiwan,
including late marriage, older childbearing age, and
increased use of artificial reproductive technologies and
services. Use of artificial reproductive technologies is
known to increase the likelihood of preterm birth, multi-
ple-gestation pregnancies, and other high-risk conditions
[32,33]. Lower fertility and getting pregnant later in life
may increase the use of artificial reproductive technolo-
gies, which in turn may increase inpatient tocolytic treat-
ment. Recent statistics by the Bureau of Health Promotion
indicate that the use of artificial reproductive technologies
has increased slightly from 1998 to 2006 [34]. We were
unable to control for the use of artificial reproductive
technologies in our analysis because such use is not cov-
ered by Taiwanese National Health Insurance and the uti-
lization data are unavailable in the National Health
Insurance claims file. Research is needed to explore the
relationship between use of artificial reproductive tech-
nologies and tocolytic treatment and the findings could
have both clinical and policy implications.
A third explanation is that pregnant women may request
tocolytic treatment on the assumption that the treatment
ensures a better birth outcome. A high premium is placed
on babies as a result of decreased fertility and fewer chil-
dren per family. Thus, the relationship between low fertil-
ity and high use of tocolytic hospitalizations possibly
reflects a higher social value of newborns.
Some of these explanations suggest potential misuse of
tocolytic hospitalizations and would warrant further
investigation. For example, if increased use of tocolytic
hospitalizations is largely explained by provider financial
incentives, then reimbursement policies should be
adjusted to prevent unnecessary use. Alternatively, if toco-
lytic hospitalizations are made primarily by maternal
requests, a public education campaign may be effective in
reducing overuse.
Also interesting are our findings that tocolytic hospitaliza-
tions were influenced by not only clinical factors but also
physician and institutional conditions that had little rele-
vance to clinical considerations. A possible explanation is
that high-risk deliveries may have much better outcomes
when they are transferred to a tertiary-level hospital with
a high volume of obstetric and neonatal services [35].
Therefore, tertiary-level hospitals are likely to provide
more tocolytic hospitalizations. On the other hand, such
physician and institutional variations are noteworthy in
light of evidence that for women with preterm labor, toc-
olysis may be unnecessary, often ineffective, and occa-
sionally harmful [9,13,14,36,37]. Is it possible that
ineffective and poor outcomes of inpatient tocolytic treat-
ments are associated with the physician and institutional
variations observed in this study? If so, variations in toco-
lytic hospitalizations raise access and cost concerns and
have important quality implications.
An important premise of the study is that effective strate-
gies for rational management of tocolytic hospitalizations
require a comprehensive understanding of factors affect-BMC Pregnancy and Childbirth 2009, 9:59 http://www.biomedcentral.com/1471-2393/9/59
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ing inpatient maternal services. To reduce medically
unnecessary tocolytic hospitalizations, reimbursement
policy may be the tool of choice for policymakers. For
example, under the current fee-for-service payment
scheme in Taiwan, reimbursement based on a well-
designed diagnosis-related grouping system may lead to
more appropriate use of tocolytic treatments. In addition,
continuing education for health care professionals may be
an important tool to reduce unnecessary tocolysis. Other
options to constrain overutilization include the applica-
tion of technology (e.g., the use of both the measurement
of cervicovaginal fetal fibronectin and transvaginal sono-
graphic assessment of cervical length [38]) and peer-
review of individual cases. Because evidence remains
ambiguous about the effectiveness of inpatient tocolysis,
obstetricians/gynecologists and health services researchers
should also explore the costs and effectiveness of inpa-
tient and outpatient tocolysis, using more detailed clinical
data and well-controlled study design to provide more
convincing empirical evidence. Future research could also
assess the relationship between tocolytic care and conse-
quential maternal as well as neonatal health outcomes.
Conclusion
Overall, our study shows that the provision of inpatient
tocolysis is influenced not only by clinical considerations
but also by physician, institutional, and area factors unre-
lated to clinical need. Physician financial incentive,
increasing use of artificial reproductive technologies, and
higher social value of newborns may explain the correla-
tion between declining fertility and rate on the use of
inpatient tocolysis. Physician and institutional variations
observed in the study indicate potential misuse of inpa-
tient tocolysis that warrant further investigation.
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